Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K S Hasan

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|July 15, 2004
Type 2 diabetes mellitus in childrenJ H Pohl, J A Greer, K S Hasan
JPMA. the Journal of the Pakistan Medical Association|September 1, 1981
Trabeculectomy--a short term follow-upK S Hasan, G Rabbani, S Hashmani, et al.
Diabetes|June 1, 1993
Hyperglycemic pseudohypoxia and diabetic complicationsJ R Williamson, K Chang, M Frangos, et al.
Diabetes|April 11, 1992
Aminoguanidine, a novel inhibitor of nitric oxide formation, prevents diabetic vascular dysfunctionJ A Corbett, R G Tilton, K Chang, et al.
Diabetes|February 1, 1993
Prevention of diabetic vascular dysfunction by guanidines. Inhibition of nitric oxide synthase versus advanced glycation end-product formationR G Tilton, K Chang, K S Hasan, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|July 15, 2004
Type 2 diabetes mellitus in childrenJ H Pohl, J A Greer, K S Hasan
JPMA. the Journal of the Pakistan Medical Association|September 1, 1981
Trabeculectomy--a short term follow-upK S Hasan, G Rabbani, S Hashmani, et al.
Diabetes|June 1, 1993
Hyperglycemic pseudohypoxia and diabetic complicationsJ R Williamson, K Chang, M Frangos, et al.
Diabetes|April 11, 1992
Aminoguanidine, a novel inhibitor of nitric oxide formation, prevents diabetic vascular dysfunctionJ A Corbett, R G Tilton, K Chang, et al.
Diabetes|February 1, 1993
Prevention of diabetic vascular dysfunction by guanidines. Inhibition of nitric oxide synthase versus advanced glycation end-product formationR G Tilton, K Chang, K S Hasan, et al.
Pageof 1